Beovu 120 mg/ml solution for injection in pre-filled syringe

Company:
Novartis Ireland Limited
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Brolucizumab
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/19/1417/001-002

120 milligram(s)

S01LA06

Solution for injection